V
This company focuses on developing improved therapeutic solutions for Valley Fever, a fungal infection caused by inhaling *Coccidioides* spores. They address the need for better treatments for Coccidioidomycosis, particularly for those in endemic regions facing increasing infection risks. Their work aims to provide advanced options for managing this serious, often underdiagnosed, fungal disease.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company focuses on developing improved therapeutic solutions for Valley Fever, a fungal infection caused by inhaling *Coccidioides* spores. They address the need for better treatments for Coccidioidomycosis, particularly for those in endemic regions facing increasing infection risks. Their work aims to provide advanced options for managing this serious, often underdiagnosed, fungal disease.